• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[口服抗癌药物的长期给药评估]

[Evaluation of long-term administration of oral anti-cancer agent].

作者信息

Watanabe H, Sakakibara N

机构信息

Dept. of Surgery 1, Juntendo University School of Medicine.

出版信息

Gan To Kagaku Ryoho. 1993 Apr;20(5):637-42.

PMID:8470922
Abstract

To evaluate the effectiveness of surgical adjuvant chemotherapy, we attempted to determine whether cancer patients were taking oral anticancer agents properly. Tegafur or UFT was administrated orally to patients with gastric or colorectal cancers after surgery for at least a year. There were 19 gastric cancer patients and 18 colorectal cancer patients. Serum levels of Tegafur and 5-FU were measured every three months. Results of the study showed that all the patients took medicine regularly according to the prescription and serum 5-FU levels of most patients (75%) exceeded the minimal effective serum level.

摘要

为评估手术辅助化疗的效果,我们试图确定癌症患者是否正确服用口服抗癌药物。对胃癌或结直肠癌患者术后口服替加氟或优福定,疗程至少一年。其中胃癌患者19例,结直肠癌患者18例。每三个月检测一次替加氟和5-氟尿嘧啶的血清水平。研究结果显示,所有患者均按处方规律服药,大多数患者(75%)的血清5-氟尿嘧啶水平超过最低有效血清水平。

相似文献

1
[Evaluation of long-term administration of oral anti-cancer agent].[口服抗癌药物的长期给药评估]
Gan To Kagaku Ryoho. 1993 Apr;20(5):637-42.
2
[The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
Gan To Kagaku Ryoho. 1988 Aug;15(8):2319-23.
3
[5-FU concentration in the blood and tissue of patients with gastric and colorectal cancer after administration of UFT or tegafur].
Gan To Kagaku Ryoho. 1986 Aug;13(8):2618-24.
4
Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.表柔比星、顺铂、口服尿嘧啶替加氟和亚叶酸钙用于晚期胃癌患者的II期试验
Cancer. 2001 Jun 15;91(12):2288-93.
5
[Pharmacokinetic study of UFT in cancer patients receiving maintenance dialysis].接受维持性透析的癌症患者中优福定的药代动力学研究
Gan To Kagaku Ryoho. 1995 Feb;22(2):239-44.
6
[Blood concentrations of futraful, uracil and 5-fluorouracil (5-FU) after UFT administration in the various reconstructions after gastrectomy. Saitama UFT Research Group].
Gan To Kagaku Ryoho. 1992 Nov;19(13):2181-7.
7
[5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].[口服优福定后宫颈癌患者血清及组织中5-氟尿嘧啶、替加氟及尿嘧啶的浓度]
Gan To Kagaku Ryoho. 1986 Feb;13(2):349-55.
8
[Clinical effect of postoperative adjuvant chemotherapy for advanced colorectal cancer--comparisons of between tegafur (FT) and UFT].[替加氟(FT)与优福定(UFT)用于晚期结直肠癌术后辅助化疗的临床疗效比较]
Gan To Kagaku Ryoho. 1991 Oct;18(13):2315-24.
9
[Concentration of 5-fluorouracil in the blood and tissues of gastric and colo-rectal cancer patients after oral administration of UFT].
Gan To Kagaku Ryoho. 1992 Nov;19(13):2175-80.
10
[Portal-transfer of an orally administered anti-cancer agent analysis of the time course of portal blood and systemic blood levels of preoperatively administered UFT].[口服抗癌药的门静脉转运:术前给予优福定后门静脉血和全身血药浓度的时程分析]
Gan To Kagaku Ryoho. 1994 Mar;21(4):501-5.